Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2024 8:35am
New Press Release - PharmAla Closes Private Placement and Concurrent Debt Settlement
VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules...
read article.
(176)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Apr 16, 2024 4:56pm
TD and CIBC
I see both institutions are still working the stock, as they are many other stocks. TD is like a virus infecting nearly every stock I invest in. These institutions have exempt status in
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Apr 13, 2024 7:36am
RE:RE:Nick CEO comments.
Notice he states "nationwide", not globally...since the recent webinar discussing insurance...maybe the next news being released has to do with that..."making MDMA more accessible
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Apr 13, 2024 7:25am
RE:Nick CEO comments.
Here is the last paragraph. .. "Over the next few weeks, we're also excited to announce the next step in PharmAla's work to expand MDMA access to more prescribers nationwide. Stay
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Post by
Firepoker
on Apr 12, 2024 8:29pm
Nick CEO comments.
Taken From Nick''s LinkedIn account. In the last paragraph, Nick hints at news coming soon. Nick Kadysh CEO at PharmAla Biotech (MDMA.CSE), Board Chair at Psychedelics Canada
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Apr 10, 2024 9:00pm
RE:if this PP has ticotime2020 and northernman in it
"the Offering will be funded solely by a small group of long-term shareholders, known to the Company, who have expressed commitments." Tico said no...but appears to be in the know. ..and
...more
(158)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Apr 10, 2024 6:00pm
if this PP has ticotime2020 and northernman in it
I will cry alll night long and day forver There is no way nick buckled and gave in to these shysters, I will be asking him personally
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 10, 2024 4:30pm
New Press Release - PharmAla Announces Private Placement and Concurrent Debt Settlement
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules...
read article.
(176)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Apr 09, 2024 5:10pm
Cena Life Webinar Tomorrow with Pharmala
Tomorrow is the Webinar between Pharmala and Cena Life CEO and COO {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=Ao5pPsCh77s|(fs)True|(loop)False|(autoplay
...more
(158)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Apr 09, 2024 9:17am
super ironic
that the shysters who were shorting this stock are from Red light Holland and now we are partners So ironic
(158)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Apr 08, 2024 11:50am
ceo duplicates
the red barron is scorpion king nothernman is tombstone and another one
(158)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Apr 08, 2024 9:53am
the pressure cooker top has been removed
this stock is ready to explode
(158)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Apr 08, 2024 9:26am
why does ceo.ca allow duplicate accounts?
but only for a select few??? that si.te is trash and full of shyster traders if you use ceo.ca...you deserve to lose your money
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Apr 07, 2024 12:05pm
RE:Insurance coverage for therapy
Alberta Blue Cross has already approved insurance coverage for psychedelic assisted therapy in 2002 for certain patients...so when FDA approval is given in August for the others ...and Blue Cross has
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income